Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin Article

Industry Collaboration International Collaboration

cited authors

  • Reck, Martin; Thatcher, Nick; Smit, Egbert F.; Lorigan, Paul; Szutowicz-Zielinska, Ewa; Liepa, Astra M.; Winfree, Katherine B.; Peterson, Patrick; Guba, Susan C.; Socinski, Mark A.

authors

Publication Date

  • December 1, 2012

webpage

published in

category

keywords

  • Etoposide plus carboplatin
  • Extensive-stage disease small cell lung cancer (ED-SCLC)
  • Functional Assessment of Cancer Therapy (FACT) scale
  • Pemetrexed plus carboplatin
  • Performance status
  • Prognostic factors

start page

  • 276

end page

  • 281

volume

  • 78

issue

  • 3